Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2<sup>G2019S</sup> model of Parkinson's disease.

eLife·2025
Same author

Retraction Note to: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

Oncogene·2025
Same author

Retraction Note: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

Oncogene·2025
Same author

Retraction Note: Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.

Oncogene·2025
Same author

Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.

Oncogene·2025
Same author

Retraction Note: A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.

Oncogene·2025

Related Experiment Video

Updated: Dec 16, 2025

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
09:58

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

2.5K

Rotating Magnetic Nanoparticle Clusters as Microdevices for Drug Delivery.

Alexander J Willis1, Sebastian P Pernal2, Zachary A Gaertner3

  • 1Division of Hematology-Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL, USA.

International Journal of Nanomedicine
|July 2, 2020
PubMed
Summary
This summary is machine-generated.

Rotational magnetic nanoparticles (MNPs) show promise for targeted drug delivery, moving across surfaces faster than diffusion. This study investigated factors affecting MNP velocity and successful drug transport in vitro.

Keywords:
etoposideglioblastomain vitro modeliron oxide nanoparticleslung cancermagnetic drug targetingnanodevice

More Related Videos

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.1K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Related Experiment Videos

Last Updated: Dec 16, 2025

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
09:58

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

2.5K
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.1K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Magnetic nanoparticles (MNPs) offer potential for enhanced therapeutic agent delivery.
  • MNPs can function as miniature propellers in fluid-filled body conduits.
  • Rotational magnetic targeting (rMDT) utilizes rotating magnets to move MNP clusters.

Purpose of the Study:

  • To understand fundamental principles of rotational magnetic drug targeting (rMDT).
  • To analyze factors affecting MNP delivery, such as cellular adhesion.
  • To evaluate MNP-mediated drug transport efficiency.

Main Methods:

  • Tested translational movement of iron oxide MNPs using a rotating magnet.
  • Analyzed MNP velocity over biomimetic channels with varying distances and cellular coatings.
  • Transported dyes and etoposide using MNP clusters over a 10 cm distance.

Main Results:

  • MNP velocities were predictable and influenced by magnetic separation times, distance, and orientation.
  • Fastest MNP velocities ranged from 0.18 to 0.28 cm/sec over different cell types.
  • MNP-mediated dye delivery was 21.7 times faster than diffusion, accelerating etoposide delivery.

Conclusions:

  • The in vitro system allows for comparative analysis of drug delivery by rotating MNP clusters.
  • These microdevices show potential for augmenting drug delivery in various clinical settings.
  • Further research is needed to optimize MNP adherence and velocity for clinical application.